Torthaí cuardaigh - Dara L. Aisner

Beachtaigh na torthaí
  1. 1
    Molecular Pathology of Non–Small Cell Lung Cancer

    Molecular Pathology of Non–Small Cell Lung Cancer de réir Dara L. Aisner, Carrie B. Marshall

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy

    Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy de réir Susan J. Hsiao, Ahmet Zehir, Anthony Sireci, Dara L. Aisner

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    BRAF VE1 Immunoreactivity Patterns in Epithelioid Glioblastomas Positive for BRAF V600E Mutation

    BRAF VE1 Immunoreactivity Patterns in Epithelioid Glioblastomas Positive for BRAF V600E Mutation de réir Bette K. Kleinschmidt‐DeMasters, Dara L. Aisner, Nicholas K. Foreman

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Lack of cell cycle regulation of telomerase activity in human cells

    Lack of cell cycle regulation of telomerase activity in human cells de réir Shawn E. Holt, Dara L. Aisner, Jerry W. Shay, Woodring E. Wright

    Foilsithe / Cruthaithe 1997
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation

    Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation de réir Bette K. Kleinschmidt‐DeMasters, Dara L. Aisner, Diane K. Birks, Nicholas K. Foreman

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Anaplastic PXA in adults: case series with clinicopathologic and molecular features

    Anaplastic PXA in adults: case series with clinicopathologic and molecular features de réir Yao Schmidt, Bette K. Kleinschmidt‐DeMasters, Dara L. Aisner, Kevin O. Lillehei, Denise Damek

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR- Mutant Non–Small Cell Lung Cancer

    Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR- Mutant Non–Small Cell... de réir Emily R. York, Marileila Varella‐Garcia, Tami J. Bang, Dara L. Aisner, D. Ross Camidge

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancer

    Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancer de réir Andrew Weickhardt, Dara L. Aisner, Wilbur A. Franklin, Marileila Varella‐Garcia, Robert C. Doebele, D. Ross Camidge

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    An Alternate Splicing Variant of the Human Telomerase Catalytic Subunit Inhibits Telomerase Activity

    An Alternate Splicing Variant of the Human Telomerase Catalytic Subunit Inhibits Telomerase Activity de réir Xiaoming Yi, Dennis M. White, Dara L. Aisner, Joseph A. Baur, Woodring E. Wright, Jerry W. Shay

    Foilsithe / Cruthaithe 2000
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    <i>PIK3CA</i>Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

    <i>PIK3CA</i>Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer de réir Aryana R. Rasti, Amy Guimaraes-Young, Farrah Mikhail Datko, Virginia F. Borges, Dara L. Aisner, Elena Shagisultanova

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Targeting the WNT Signaling Pathway in Cancer Therapeutics

    Targeting the WNT Signaling Pathway in Cancer Therapeutics de réir David Tai, Keith Wells, John J. Arcaroli, Chad Vanderbilt, Dara L. Aisner, Wells A. Messersmith, Christopher H. Lieu

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer

    DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer de réir Kurtis D. Davies, Aprille Lomboy, Carolyn A. Lawrence, Michael Yourshaw, Gregary T. Bocsi, D. Ross Camidge, Dara L. Aisner

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Atypical Negative ALK Break-Apart FISH Harboring a Crizotinib-Responsive ALK Rearrangement in Non–Small-Cell Lung Cancer

    Atypical Negative ALK Break-Apart FISH Harboring a Crizotinib-Responsive ALK Rearrangement in Non–Small-Cell Lung Cancer de réir Shengxiang Ren, Fred R. Hirsch, Marileila Varella‐Garcia, Dara L. Aisner, Theresa A. Boyle, Caicun Zhou, D. Ross Camidge

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer

    An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer de réir Rafał Dziadziuszko, Anh T. Le, Anna Wrona, Jacek Jassem, D. Ross Camidge, Marileila Varella‐Garcia, Dara L. Aisner, Robert C. Doebele

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers

    HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers de réir Bob T. Li, Dara S. Ross, Dara L. Aisner, Jamie E. Chaft, Meier Hsu, Severine Kako, Mark G. Kris, Marileila Varella‐Garcia, Maria E. Arcila

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Dramatic Response to Crizotinib in a Patient With Lung Cancer Positive for an <i>HLA-DRB1-MET</i> Gene Fusion

    Dramatic Response to Crizotinib in a Patient With Lung Cancer Positive for an <i>HLA-DRB1-MET</i> Gene Fusion de réir Kurtis D. Davies, Terry L. Ng, Adriana Estrada‐Bernal, Anh T. Le, Peter R. Ennever, D. Ross Camidge, Robert C. Doebele, Dara L. Aisner

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Two Inactive Fragments of the Integral RNA Cooperate To Assemble Active Telomerase with the Human Protein Catalytic Subunit (hTERT) In Vitro

    Two Inactive Fragments of the Integral RNA Cooperate To Assemble Active Telomerase with the Human Protein Catalytic Subunit (hTERT) In Vitro de réir Valerie M. Tesmer, Lance P. Ford, Shawn E. Holt, Bryan Frank, Xiaoming Yi, Dara L. Aisner, Michel Ouellette, Jerry W. Shay, Woodring E. Wright

    Foilsithe / Cruthaithe 1999
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples

    Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples de réir Kurtis D. Davies, Anh‐Tuan Le, Jamie Sheren, Hala Nijmeh, Katherine Gowan, Kenneth L. Jones, Marileila Varella‐Garcia, Dara L. Aisner, Robert C. Doebele

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Activation of RAS family members confers resistance to ROS1 targeting drugs

    Activation of RAS family members confers resistance to ROS1 targeting drugs de réir Marilisa Cargnelutti, Simona Corso, Margherita Pergolizzi, Laurence Mévellec, Dara L. Aisner, Rafał Dziadziuszko, Marileila Varella‐Garcia, Paolo M. Comoglio, Robert C. Doebele, Jorge Vialard, Silvia Giordano

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non–Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib

    The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non–Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib de réir Tejas Patil, Derek Smith, Paul A. Bunn, Dara L. Aisner, Anh T. Le, Mark J. Hancock, W. Thomas Purcell, Daniel W. Bowles, D. Ross Camidge, Robert C. Doebele

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: